Single Topic Symposium: STOPNASH

Module 1: Clinical Patterns and Early Influences on NAFLD

Patterns of NAFLD around the world
Jeff Schwimmer MD, University of California, San Diego

Putting NAFLD in perspective: An overview of the pathophysiology
Brent A. Neuschwander‐Tetri MD, St. Louis University

Genetics plus the environment: The sugar effect on PNPLA3
Michael Goran MD, Keck School of Medicine, University of Southern California

NAFLD and Type II Diabetes
Sonia Caprio MD, Yale University School of Medicine

Module 2: From "Healthy" Obese to NASH ‐ What Happens?

Maternal insulin resistance and NAFLD development
Jed Friedman MD, University of Colorado School of Medicine

Fatty acid dysregulation in NAFLD
Elizabeth Parks MD, University of Missouri School of Medicine

Fructose and the liver: More than just extra calories?
Rob Lustig MD, University of California, San Francisco

Microbiome and NAFLD in children
Marialena Mouzaki MD, The Hospital for Sick Children

Genetics and NAFLD: What we know so far
Nicola Santoro MD, Yale University School of Medicine

Module 3: Initiating Mechanisms of Inflammation & Fibrosis

Crosstalk between adipocytes and hepatocytes
Nitika Gupta MD, Emory University

Oxidized lipids and linoleic acid in NASH
Christopher Ramsdam MD, National Institutes of Health

Sterile inflammation and cell death
Ariel Feldstein MD, University of California, San Diego

NASH: What's bile got to do with it?
Rohit Kohli MD, Cincinnati Children's Hospital Medical Center

Module 4: From Bench to Bassinet: Research Informing NAFLD Prevention

What dose of exercise reduces insulin resistance in children and application to NAFLD
Catherine Davis MD, Georgia Regents University

Interventions and policies to prevent obesity among vulnerable children
Jennifer Woo Baidal MD, Boston Children's Hospital

Prevention and treatment of childhood obesity: What can we learn and apply to prevention of NAFLD?
Sarah Barlow MD, Baylor College of Medicine

Module 5: Moving Forward: Research Priorities

Goals of the NASH CRN and opportunities for collaboration
Joel Lavine MD, Columbia University

NIDDK priorities and perspectives
Ed Doo MD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Opportunities for Collaboration
Veronica Miller PhD, Director, Forum for Collaborative HIV Research and The Liver Forum